Investigating the molecular mechanisms underlying the anti-CRISPR function of AcrIIA13b protein

So Yeon Lee1,2, Hyun Ho Park1,2

  • 1College of Pharmacy, Chung-Ang University, Seoul, Korea.

The FEBS Journal
|October 25, 2025
PubMed

Insights

Researchers uncovered how anti-CRISPR protein AcrIIA13b inhibits Staphylococcus aureus Cas9 (SauCas9) by blocking DNA binding. This discovery deepens our understanding of CRISPR-Cas regulation and phage-bacteria interactions.

Area of Science:

  • Molecular Biology
  • Genetics
  • Microbiology

Background:

  • CRISPR-Cas systems provide bacterial and archaeal immunity against mobile genetic elements.
  • Anti-CRISPR (Acr) proteins from phages and viruses counteract CRISPR-Cas systems.
  • Understanding Acrs is crucial for improving CRISPR-Cas genome editing safety and efficacy.

Purpose of the Study:

  • To elucidate the structural and molecular mechanisms by which AcrIIA13b inhibits Staphylococcus aureus Cas9 (SauCas9).
  • To provide insights into the regulation of CRISPR-Cas systems and the evolutionary arms race between phages and bacteria.

Main Methods:

  • X-ray crystallography to determine the structure of AcrIIA13b.
  • Biochemical assays to analyze the functional features and inhibitory activity of AcrIIA13b against SauCas9.
  • Site-directed mutagenesis to investigate the role of N-terminal amino acid residues.

Main Results:

  • The structure of AcrIIA13b was determined, revealing its interaction with SauCas9.
  • AcrIIA13b inhibits SauCas9 by blocking the Protospacer Adjacent Motif (PAM)-binding region, preventing target DNA recognition.
  • The N-terminal 15 amino acids of AcrIIA13b are critical for its dimerization and inhibitory function.

Conclusions:

  • AcrIIA13b effectively inhibits SauCas9 by sterically hindering PAM recognition.
  • The N-terminal dimerization domain of AcrIIA13b is essential for its anti-CRISPR activity.
  • These findings enhance comprehension of CRISPR-Cas inhibition mechanisms and phage-host interactions.

Related Concept Videos

CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
617
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.5K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.7K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.3K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.7K